Cargando...
Cardiotoxicity from immune checkpoint inhibitors
Immune checkpoint inhibitor (ICI) therapy has greatly improved treatment of various advanced cancers but increasing use of ICI therapy has exposed the risk of ICI-related cardiovascular side effects. Immune checkpoints are inhibitory regulators of T cell activation and mediate T cell effector functi...
Gardado en:
| Publicado en: | Int J Cardiol Heart Vasc |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736791/ https://ncbi.nlm.nih.gov/pubmed/31517036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2019.100420 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|